Australia’s home-grown biotech giant saw half-year net profits drop as constraints on plasma collection start to impact sales revenues.
Brisbane Times – Business
Business
More in:Business
Business
How this Aussie appliance-maker dodged Trump’s tariff bullet
Breville’s avoidance of the full hit from US duties is testament to its agility, and ...
Business
Solid gold stacks up for Auric in Kalgoorlie
Auric Mining has started the year strong, with its Munda mine in WA delivering a ...
Business
Dateline chases mine-life growth with new US gold hits
Dateline Resources has reported strong step-out drilling results at its US Colosseum project, including 150m ...